Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Woldemussie; Elizabeth
Address:
Laguna Niguel, CA
No. of patents:
17
Patents:












Patent Number Title Of Patent Date Issued
6465464 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury October 15, 2002
The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a compound of formula I to inhibit or prevent nerve cell injury or de
6410544 Cholinergic agents in the treatment of presbyopia June 25, 2002
A method for increasing or decreasing parasympathetic/cholinergic/ciliary tonic contraction in order to restore the resting portion of the eye and allow normal positive and negative accommodation includes administering to a myopic or hyperopic presbyope.
6291466 Cholinergic agents in the treatment of presbyopia September 18, 2001
A method for increasing or decreasing parasympathetic/cholinergic/ciliary tonic contraction in order to restore the resting portion of the eye and allow normal positive and negative accommodation includes administering to a presbyopic subject an effective amount of a muscarinic agent.
6248741 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury June 19, 2001
The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a compound of formula I to inhibit or prevent nerve cell injury or de
6194415 Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury February 27, 2001
The present invention provides a method of protecting the optic or retinal nerve cells of a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on said nerve cells an effective amount of a compound of formula I to inhibit or prevent nerv
6164282 Methods for restoring and/or enhancing accommodation in pseudo phakia December 26, 2000
A method for increasing the amount of accommodation in an eye of a mammal which eye includes an artificial intraocular lens. The method provides for administering to the mammal the amount of a muscarinic agent necessary to restore tonic accommodation.
6077839 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobu June 20, 2000
Ophthalmic compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by topically administering to the mammalian eye the ophthalmic composition of the invention which contains as the active ingredient one or more gamma aminobutyric acid
5925342 Method for reducing intraocular pressure in the mammalian eye by administration of potassium cha July 20, 1999
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having potass
5891911 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chela April 6, 1999
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains as the active ingredient one or more compounds having calcium
5866605 Method for providing a neuroprotective effect to the mammalian eye by administration of chloride February 2, 1999
Pharmaceutical compositions and a method are disclosed for providing neuroprotective effect to the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chloride chann
5856329 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury January 5, 1999
A method according to which neuroprotection is conferred upon ocular nerve cells by administration of a drug of formula I to the optic nerve and/or retina of a mammal within a period prior to or following an insult to ocular nerve cells but prior to cell death ##STR1## wherein th
5716952 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic an February 10, 1998
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains as the active ingredient one or more muscarinic antagonist
5705530 Method for reducing intraocular pressure in the mammalian eye by administration of chloride chan January 6, 1998
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chlori
5677327 Method for identifying muscarinic agents lacking miotic side effects October 14, 1997
The present invention provides a method for identifying a compound having muscarinic agonist activity that will lower intraocular pressure without causing miosis which comprises measuring the activity of the compound at the m.sub.3 and m.sub.5 muscarinic receptors and determining from th
5573758 Method for reducing intraocular pressure in the mammalian eye by administration of potassium cha November 12, 1996
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having potass
5559151 Method for reducing intraocular pressure in the mammalian eye by administration of chloride chan September 24, 1996
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chlori
5521210 Ophthalmic use of muscarinic agonists having increased duration of activity May 28, 1996
A method for inducing prolonged pseudoaccommodation includes the instillation of an ophthalmic formulation into an eye for contracting the iris sphincter muscle, but not the ciliary muscle, in order to cause sphincter muscle contraction for a period of greater than about one hour per










 
 
  Recently Added Patents
Systems and methods for facilitating communication with foundation fieldbus linking devices
Multi-room user interface
Intermediate film for laminated glasses, and laminated glass
Data processing system, data processing method, and image forming apparatus
Strongly bound carbon nanotube arrays directly grown on substrates and methods for production thereof
State control of remote hosts for management of distributed applications
Nanocatalysts structure, process for the preparation and use thereof
  Randomly Featured Patents
Method and apparatus for preparing cells for examination
Method and apparatus for efficient certificate revocation
Hydantoin derivatives
Pin socket with connecting portions
Method for sorting paperboard blanks
Multi-voltage control circuit of tree branch network
Gymnastic apparatus
Marine motor drive assembly
Vehicular safety arrangement for driver's seat
Outboard motor